ゾメディカは、トゥルフォーマインクリニックバイオセンサーテストプラットフォーム向けのエキュインプラズマ用インスリンアッセイ第3弾を発売しました

Benzinga · 2024/11/14 19:43

Veterinarians test equine insulin levels when they suspect Equine Metabolic Syndrome (EMS) or other forms of insulin dysregulation, as frequently occurs with equine Cushing's disease, or Pituitary Pars Intermedia Dysfunction (PPID), with prevalence reported between 18-27% of ponies and horses. Left untreated, laminitis, which can lead to euthanasia, is a consequence of both EMS and PPID.
The TRUFORMA Insulin assay offers quantitative detection of insulin levels in equine plasma, with results available in just 18 minutes. This rapid turnaround enables veterinarians to diagnose and monitor insulin dysregulation in horses quickly, eliminating the need for reference laboratory wait times and allowing for immediate treatment decisions. The assay is designed for both in-clinic and stall-side use, providing flexibility for various clinical settings. Importantly, Zomedica offers this advanced diagnostic capability with no capital outlay or monthly minimums from veterinary practices.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。更に詳しい情報

Zomedica Has Launched Its Third Equine-focused Assay-insulin For Equine Plasma-For Truforma In-Clinic Biosensor Testing Platform